申请人:Purdue Research Foundation
公开号:US20140187547A1
公开(公告)日:2014-07-03
The invention described herein pertains to substituted azaindenoisoquinoline compounds, in particular 7-, 8-, 9-, and 10-azaindenoisoquinoline compounds, which are inhibitors of topoisomerase I, processes and intermediates for their syntheses, pharmaceutical compositions of the compounds, and methods of using them in the treatment of cancer.
本发明涉及取代的氮杂茚异异喹啉化合物,特别是7-、8-、9-和10-氮杂茚异异喹啉化合物,它们是拓扑异构酶I的抑制剂,其合成的过程和中间体,这些化合物的制药组合物以及使用它们治疗癌症的方法。